APO Research
Talk to an analyst

APO RESEARCH · REPORT

Voriconazole

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Voriconazole Market Analysis and Forecast 2026-2032

26 December 2025201 pages

Choose your research edition.

Industry ResearchVoriconazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Voriconazole Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Voriconazole Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Voriconazole Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Voriconazole market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Voriconazole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Voriconazole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Voriconazole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Voriconazole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Voriconazole include Abbott, Takeda, Teva, Sandoz, 诺华, Mylan, Pfizer, GSK and Taj Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Voriconazole, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Voriconazole, also provides the sales of main regions and countries. Of the upcoming market potential for Voriconazole, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Voriconazole sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Voriconazole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Voriconazole sales, projected growth trends, production technology, application and end-user industry.

Voriconazole Segment by Company

Abbott

Takeda

Teva

Sandoz

诺华

Mylan

Pfizer

GSK

Taj Pharmaceuticals

Squibb

Sichuan Beauty Sport Huakang Pharmaceutical

Macherey-Nagel GmbH

Jincheng HEALTH Pharmaceutical

GeneTech Pharm

Ebang Pharmaceutical

Daiichi Sankyo

Cilag AG

Aditya Pharma

Voriconazole Segment by Type

Injection Voriconazole

Voriconazole Freeze-dried Powder

Voriconazole Segment by Application

Hospital

Clinic

Other

Voriconazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voriconazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voriconazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voriconazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Voriconazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Voriconazole sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Voriconazole Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Voriconazole Major Manufacturers Table 3. Voriconazole Freeze-dried Powder Major Manufacturers Table 4. Global Voriconazole Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Voriconazole Industry Trends Table 9. Voriconazole Industry Drivers Table 10. Voriconazole Industry Opportunities and Challenges Table 11. Voriconazole Industry Restraints Table 12. Global Voriconazole Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Voriconazole Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Voriconazole Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Voriconazole Revenue Market Share by Region (2021-2026) Table 16. Global Voriconazole Revenue Market Share by Region (2027-2032) Table 17. Global Voriconazole Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Voriconazole Sales by Region (2021-2026) & (K Units) Table 19. Global Voriconazole Sales by Region (2027-2032) & (K Units) Table 20. Global Voriconazole Sales Market Share by Region (2021-2026) Table 21. Global Voriconazole Sales Market Share by Region (2027-2032) Table 22. Global Voriconazole Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Voriconazole Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Voriconazole Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Voriconazole Sales Market Share by Manufacturers (2021-2026) Table 26. Global Voriconazole Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Voriconazole Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Voriconazole Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Voriconazole Manufacturers, Product Type & Application Table 30. Global Voriconazole Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Voriconazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Voriconazole Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Voriconazole Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Voriconazole Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Voriconazole Revenue Market Share by Type (2021-2026) Table 37. Global Voriconazole Revenue Market Share by Type (2027-2032) Table 38. Global Voriconazole Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Voriconazole Sales by Type (2021-2026) & (K Units) Table 40. Global Voriconazole Sales by Type (2027-2032) & (K Units) Table 41. Global Voriconazole Sales Market Share by Type (2021-2026) Table 42. Global Voriconazole Sales Market Share by Type (2027-2032) Table 43. Global Voriconazole Price by Type (2021-2026) & (US$/Unit) Table 44. Global Voriconazole Price by Type (2027-2032) & (US$/Unit) Table 45. Global Voriconazole Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Voriconazole Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Voriconazole Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Voriconazole Revenue Market Share by Application (2021-2026) Table 49. Global Voriconazole Revenue Market Share by Application (2027-2032) Table 50. Global Voriconazole Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Voriconazole Sales by Application (2021-2026) & (K Units) Table 52. Global Voriconazole Sales by Application (2027-2032) & (K Units) Table 53. Global Voriconazole Sales Market Share by Application (2021-2026) Table 54. Global Voriconazole Sales Market Share by Application (2027-2032) Table 55. Global Voriconazole Price by Application (2021-2026) & (US$/Unit) Table 56. Global Voriconazole Price by Application (2027-2032) & (US$/Unit) Table 57. Abbott Company Information Table 58. Abbott Business Overview Table 59. Abbott Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Abbott Voriconazole Product Portfolio Table 61. Abbott Recent Development Table 62. Takeda Company Information Table 63. Takeda Business Overview Table 64. Takeda Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Takeda Voriconazole Product Portfolio Table 66. Takeda Recent Development Table 67. Teva Company Information Table 68. Teva Business Overview Table 69. Teva Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Teva Voriconazole Product Portfolio Table 71. Teva Recent Development Table 72. Sandoz Company Information Table 73. Sandoz Business Overview Table 74. Sandoz Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sandoz Voriconazole Product Portfolio Table 76. Sandoz Recent Development Table 77. 诺华 Company Information Table 78. 诺华 Business Overview Table 79. 诺华 Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. 诺华 Voriconazole Product Portfolio Table 81. 诺华 Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan Voriconazole Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Voriconazole Product Portfolio Table 91. Pfizer Recent Development Table 92. GSK Company Information Table 93. GSK Business Overview Table 94. GSK Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GSK Voriconazole Product Portfolio Table 96. GSK Recent Development Table 97. Taj Pharmaceuticals Company Information Table 98. Taj Pharmaceuticals Business Overview Table 99. Taj Pharmaceuticals Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Taj Pharmaceuticals Voriconazole Product Portfolio Table 101. Taj Pharmaceuticals Recent Development Table 102. Squibb Company Information Table 103. Squibb Business Overview Table 104. Squibb Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Squibb Voriconazole Product Portfolio Table 106. Squibb Recent Development Table 107. Sichuan Beauty Sport Huakang Pharmaceutical Company Information Table 108. Sichuan Beauty Sport Huakang Pharmaceutical Business Overview Table 109. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio Table 111. Sichuan Beauty Sport Huakang Pharmaceutical Recent Development Table 112. Macherey-Nagel GmbH Company Information Table 113. Macherey-Nagel GmbH Business Overview Table 114. Macherey-Nagel GmbH Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Macherey-Nagel GmbH Voriconazole Product Portfolio Table 116. Macherey-Nagel GmbH Recent Development Table 117. Jincheng HEALTH Pharmaceutical Company Information Table 118. Jincheng HEALTH Pharmaceutical Business Overview Table 119. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio Table 121. Jincheng HEALTH Pharmaceutical Recent Development Table 122. GeneTech Pharm Company Information Table 123. GeneTech Pharm Business Overview Table 124. GeneTech Pharm Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GeneTech Pharm Voriconazole Product Portfolio Table 126. GeneTech Pharm Recent Development Table 127. Ebang Pharmaceutical Company Information Table 128. Ebang Pharmaceutical Business Overview Table 129. Ebang Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Ebang Pharmaceutical Voriconazole Product Portfolio Table 131. Ebang Pharmaceutical Recent Development Table 132. Daiichi Sankyo Company Information Table 133. Daiichi Sankyo Business Overview Table 134. Daiichi Sankyo Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Daiichi Sankyo Voriconazole Product Portfolio Table 136. Daiichi Sankyo Recent Development Table 137. Cilag AG Company Information Table 138. Cilag AG Business Overview Table 139. Cilag AG Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Cilag AG Voriconazole Product Portfolio Table 141. Cilag AG Recent Development Table 142. Aditya Pharma Company Information Table 143. Aditya Pharma Business Overview Table 144. Aditya Pharma Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Aditya Pharma Voriconazole Product Portfolio Table 146. Aditya Pharma Recent Development Table 147. North America Voriconazole Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Voriconazole Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Voriconazole Sales by Type (2021-2026) & (K Units) Table 150. North America Voriconazole Sales by Type (2027-2032) & (K Units) Table 151. North America Voriconazole Sales Price by Type (2021-2026) & (US$/Unit) Table 152. North America Voriconazole Sales Price by Type (2027-2032) & (US$/Unit) Table 153. North America Voriconazole Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Voriconazole Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Voriconazole Sales by Application (2021-2026) & (K Units) Table 156. North America Voriconazole Sales by Application (2027-2032) & (K Units) Table 157. North America Voriconazole Sales Price by Application (2021-2026) & (US$/Unit) Table 158. North America Voriconazole Sales Price by Application (2027-2032) & (US$/Unit) Table 159. North America Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Voriconazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Voriconazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Voriconazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. North America Voriconazole Sales by Country (2021-2026) & (K Units) Table 164. North America Voriconazole Sales by Country (2027-2032) & (K Units) Table 165. North America Voriconazole Sales Price by Country (2021-2026) & (US$/Unit) Table 166. North America Voriconazole Sales Price by Country (2027-2032) & (US$/Unit) Table 167. United States Voriconazole Revenue (2021-2032) & (US$ Million) Table 168. Canada Voriconazole Revenue (2021-2032) & (US$ Million) Table 169. Mexico Voriconazole Revenue (2021-2032) & (US$ Million) Table 170. Europe Voriconazole Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Voriconazole Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Voriconazole Sales by Type (2021-2026) & (K Units) Table 173. Europe Voriconazole Sales by Type (2027-2032) & (K Units) Table 174. Europe Voriconazole Sales Price by Type (2021-2026) & (US$/Unit) Table 175. Europe Voriconazole Sales Price by Type (2027-2032) & (US$/Unit) Table 176. Europe Voriconazole Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Voriconazole Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Voriconazole Sales by Application (2021-2026) & (K Units) Table 179. Europe Voriconazole Sales by Application (2027-2032) & (K Units) Table 180. Europe Voriconazole Sales Price by Application (2021-2026) & (US$/Unit) Table 181. Europe Voriconazole Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Europe Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Voriconazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Voriconazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Voriconazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. Europe Voriconazole Sales by Country (2021-2026) & (K Units) Table 187. Europe Voriconazole Sales by Country (2027-2032) & (K Units) Table 188. Europe Voriconazole Sales Price by Country (2021-2026) & (US$/Unit) Table 189. Europe Voriconazole Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Germany Voriconazole Revenue (2021-2032) & (US$ Million) Table 191. France Voriconazole Revenue (2021-2032) & (US$ Million) Table 192. U.K. Voriconazole Revenue (2021-2032) & (US$ Million) Table 193. Italy Voriconazole Revenue (2021-2032) & (US$ Million) Table 194. Russia Voriconazole Revenue (2021-2032) & (US$ Million) Table 195. Spain Voriconazole Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Voriconazole Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Voriconazole Revenue (2021-2032) & (US$ Million) Table 198. Sweden Voriconazole Revenue (2021-2032) & (US$ Million) Table 199. Poland Voriconazole Revenue (2021-2032) & (US$ Million) Table 200. China Voriconazole Revenue by Type (2021-2026) & (US$ Million) Table 201. China Voriconazole Revenue by Type (2027-2032) & (US$ Million) Table 202. China Voriconazole Sales by Type (2021-2026) & (K Units) Table 203. China Voriconazole Sales by Type (2027-2032) & (K Units) Table 204. China Voriconazole Sales Price by Type (2021-2026) & (US$/Unit) Table 205. China Voriconazole Sales Price by Type (2027-2032) & (US$/Unit) Table 206. China Voriconazole Revenue by Application (2021-2026) & (US$ Million) Table 207. China Voriconazole Revenue by Application (2027-2032) & (US$ Million) Table 208. China Voriconazole Sales by Application (2021-2026) & (K Units) Table 209. China Voriconazole Sales by Application (2027-2032) & (K Units) Table 210. China Voriconazole Sales Price by Application (2021-2026) & (US$/Unit) Table 211. China Voriconazole Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Asia Voriconazole Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Voriconazole Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Voriconazole Sales by Type (2021-2026) & (K Units) Table 215. Asia Voriconazole Sales by Type (2027-2032) & (K Units) Table 216. Asia Voriconazole Sales Price by Type (2021-2026) & (US$/Unit) Table 217. Asia Voriconazole Sales Price by Type (2027-2032) & (US$/Unit) Table 218. Asia Voriconazole Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Voriconazole Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Voriconazole Sales by Application (2021-2026) & (K Units) Table 221. Asia Voriconazole Sales by Application (2027-2032) & (K Units) Table 222. Asia Voriconazole Sales Price by Application (2021-2026) & (US$/Unit) Table 223. Asia Voriconazole Sales Price by Application (2027-2032) & (US$/Unit) Table 224. Asia Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Voriconazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Voriconazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Voriconazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 228. Asia Voriconazole Sales by Country (2021-2026) & (K Units) Table 229. Asia Voriconazole Sales by Country (2027-2032) & (K Units) Table 230. Asia Voriconazole Sales Price by Country (2021-2026) & (US$/Unit) Table 231. Asia Voriconazole Sales Price by Country (2027-2032) & (US$/Unit) Table 232. Japan Voriconazole Revenue (2021-2032) & (US$ Million) Table 233. South Korea Voriconazole Revenue (2021-2032) & (US$ Million) Table 234. India Voriconazole Revenue (2021-2032) & (US$ Million) Table 235. Australia Voriconazole Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Voriconazole Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Voriconazole Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Voriconazole Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Voriconazole Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Voriconazole Sales by Type (2021-2026) & (K Units) Table 241. SAMEA Voriconazole Sales by Type (2027-2032) & (K Units) Table 242. SAMEA Voriconazole Sales Price by Type (2021-2026) & (US$/Unit) Table 243. SAMEA Voriconazole Sales Price by Type (2027-2032) & (US$/Unit) Table 244. SAMEA Voriconazole Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Voriconazole Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Voriconazole Sales by Application (2021-2026) & (K Units) Table 247. SAMEA Voriconazole Sales by Application (2027-2032) & (K Units) Table 248. SAMEA Voriconazole Sales Price by Application (2021-2026) & (US$/Unit) Table 249. SAMEA Voriconazole Sales Price by Application (2027-2032) & (US$/Unit) Table 250. SAMEA Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Voriconazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Voriconazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Voriconazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 254. SAMEA Voriconazole Sales by Country (2021-2026) & (K Units) Table 255. SAMEA Voriconazole Sales by Country (2027-2032) & (K Units) Table 256. SAMEA Voriconazole Sales Price by Country (2021-2026) & (US$/Unit) Table 257. SAMEA Voriconazole Sales Price by Country (2027-2032) & (US$/Unit) Table 258. Brazil Voriconazole Revenue (2021-2032) & (US$ Million) Table 259. Argentina Voriconazole Revenue (2021-2032) & (US$ Million) Table 260. Chile Voriconazole Revenue (2021-2032) & (US$ Million) Table 261. Colombia Voriconazole Revenue (2021-2032) & (US$ Million) Table 262. Peru Voriconazole Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Voriconazole Revenue (2021-2032) & (US$ Million) Table 264. Israel Voriconazole Revenue (2021-2032) & (US$ Million) Table 265. UAE Voriconazole Revenue (2021-2032) & (US$ Million) Table 266. Turkey Voriconazole Revenue (2021-2032) & (US$ Million) Table 267. Iran Voriconazole Revenue (2021-2032) & (US$ Million) Table 268. Egypt Voriconazole Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Voriconazole Distributors List Table 272. Voriconazole Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Voriconazole Image Figure 2. Global Voriconazole Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Voriconazole Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Voriconazole Image Figure 5. Voriconazole Freeze-dried Powder Image Figure 6. Global Voriconazole Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Voriconazole Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Voriconazole Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Voriconazole Revenue (2021-2032) & (US$ Million) Figure 13. Global Voriconazole Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Voriconazole Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Voriconazole Revenue Market Share by Region (2021-2032) Figure 16. Global Voriconazole Sales (2021-2032) & (K Units) Figure 17. Global Voriconazole Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Voriconazole Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Voriconazole Sales YoY (2021-2032) & (K Units) Figure 20. Europe Voriconazole Sales YoY (2021-2032) & (K Units) Figure 21. China Voriconazole Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Voriconazole Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Voriconazole Sales YoY (2021-2032) & (K Units) Figure 24. Global Voriconazole Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Voriconazole Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Voriconazole Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Voriconazole Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Voriconazole Revenue Market Share by Type (2021-2032) Figure 30. Global Voriconazole Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Voriconazole Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Voriconazole Sales Market Share by Type (2021-2032) Figure 33. Global Voriconazole Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Voriconazole Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Voriconazole Revenue Market Share by Application (2021-2032) Figure 36. Global Voriconazole Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Voriconazole Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Voriconazole Sales Market Share by Application (2021-2032) Figure 39. North America Voriconazole Revenue Share by Type (2021-2032) Figure 40. North America Voriconazole Sales Share by Type (2021-2032) Figure 41. North America Voriconazole Revenue Share by Application (2021-2032) Figure 42. North America Voriconazole Sales Share by Application (2021-2032) Figure 43. North America Voriconazole Revenue Share by Country (2021-2032) Figure 44. North America Voriconazole Sales Share by Country (2021-2032) Figure 45. Europe Voriconazole Revenue Share by Type (2021-2032) Figure 46. Europe Voriconazole Sales Share by Type (2021-2032) Figure 47. Europe Voriconazole Revenue Share by Application (2021-2032) Figure 48. Europe Voriconazole Sales Share by Application (2021-2032) Figure 49. Europe Voriconazole Revenue Share by Country (2021-2032) Figure 50. Europe Voriconazole Sales Share by Country (2021-2032) Figure 51. China Voriconazole Revenue Share by Type (2021-2032) Figure 52. China Voriconazole Sales Share by Type (2021-2032) Figure 53. China Voriconazole Revenue Share by Application (2021-2032) Figure 54. China Voriconazole Sales Share by Application (2021-2032) Figure 55. Asia Voriconazole Revenue Share by Type (2021-2032) Figure 56. Asia Voriconazole Sales Share by Type (2021-2032) Figure 57. Asia Voriconazole Revenue Share by Application (2021-2032) Figure 58. Asia Voriconazole Sales Share by Application (2021-2032) Figure 59. Asia Voriconazole Revenue Share by Country (2021-2032) Figure 60. Asia Voriconazole Sales Share by Country (2021-2032) Figure 61. SAMEA Voriconazole Revenue Share by Type (2021-2032) Figure 62. SAMEA Voriconazole Sales Share by Type (2021-2032) Figure 63. SAMEA Voriconazole Revenue Share by Application (2021-2032) Figure 64. SAMEA Voriconazole Sales Share by Application (2021-2032) Figure 65. SAMEA Voriconazole Revenue Share by Country (2021-2032) Figure 66. SAMEA Voriconazole Sales Share by Country (2021-2032) Figure 67. Voriconazole Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Voriconazole Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Voriconazole
  • Voriconazole Freeze-dried Powder
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Takeda
  • Teva
  • Sandoz
  • 诺华
  • Mylan
  • Pfizer
  • GSK
  • Taj Pharmaceuticals
  • Squibb
  • Sichuan Beauty Sport Huakang Pharmaceutical
  • Macherey-Nagel GmbH
  • Jincheng HEALTH Pharmaceutical
  • GeneTech Pharm
  • Ebang Pharmaceutical
  • Daiichi Sankyo
  • Cilag AG
  • Aditya Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Voriconazole Market by Type
  3. 1.2.1 Global Voriconazole Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection Voriconazole
  5. 1.2.3 Voriconazole Freeze-dried Powder
  6. 1.3 Voriconazole Market by Application
  7. 1.3.1 Global Voriconazole Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Voriconazole Market Dynamics
  1. 2.1 Voriconazole Industry Trends
  2. 2.2 Voriconazole Industry Drivers
  3. 2.3 Voriconazole Industry Opportunities and Challenges
  4. 2.4 Voriconazole Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Voriconazole Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Voriconazole Revenue by Region
  3. 3.2.1 Global Voriconazole Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Voriconazole Revenue by Region (2021-2026)
  5. 3.2.3 Global Voriconazole Revenue by Region (2027-2032)
  6. 3.2.4 Global Voriconazole Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Voriconazole Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Voriconazole Sales by Region
  9. 3.4.1 Global Voriconazole Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Voriconazole Sales by Region (2021-2026)
  11. 3.4.3 Global Voriconazole Sales by Region (2027-2032)
  12. 3.4.4 Global Voriconazole Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Voriconazole Revenue by Manufacturers
  2. 4.1.1 Global Voriconazole Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Voriconazole Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Voriconazole Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Voriconazole Sales by Manufacturers
  6. 4.2.1 Global Voriconazole Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Voriconazole Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Voriconazole Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Voriconazole Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Voriconazole Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Voriconazole Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Voriconazole Manufacturers, Product Type & Application
  13. 4.7 Global Voriconazole Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Voriconazole Market CR5 and HHI
  16. 4.8.2 2025 Voriconazole Tier 1, Tier 2, and Tier 3
5 Voriconazole Market by Type
  1. 5.1 Global Voriconazole Revenue by Type
  2. 5.1.1 Global Voriconazole Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Voriconazole Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Voriconazole Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Voriconazole Sales by Type
  6. 5.2.1 Global Voriconazole Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Voriconazole Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Voriconazole Sales Market Share by Type (2021-2032)
  9. 5.3 Global Voriconazole Price by Type
6 Voriconazole Market by Application
  1. 6.1 Global Voriconazole Revenue by Application
  2. 6.1.1 Global Voriconazole Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Voriconazole Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Voriconazole Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Voriconazole Sales by Application
  6. 6.2.1 Global Voriconazole Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Voriconazole Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Voriconazole Sales Market Share by Application (2021-2032)
  9. 6.3 Global Voriconazole Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Voriconazole Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Takeda
  8. 7.2.1 Takeda Company Information
  9. 7.2.2 Takeda Business Overview
  10. 7.2.3 Takeda Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Voriconazole Product Portfolio
  12. 7.2.5 Takeda Recent Developments
  13. 7.3 Teva
  14. 7.3.1 Teva Company Information
  15. 7.3.2 Teva Business Overview
  16. 7.3.3 Teva Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Teva Voriconazole Product Portfolio
  18. 7.3.5 Teva Recent Developments
  19. 7.4 Sandoz
  20. 7.4.1 Sandoz Company Information
  21. 7.4.2 Sandoz Business Overview
  22. 7.4.3 Sandoz Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sandoz Voriconazole Product Portfolio
  24. 7.4.5 Sandoz Recent Developments
  25. 7.5 诺华
  26. 7.5.1 诺华 Company Information
  27. 7.5.2 诺华 Business Overview
  28. 7.5.3 诺华 Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 诺华 Voriconazole Product Portfolio
  30. 7.5.5 诺华 Recent Developments
  31. 7.6 Mylan
  32. 7.6.1 Mylan Company Information
  33. 7.6.2 Mylan Business Overview
  34. 7.6.3 Mylan Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mylan Voriconazole Product Portfolio
  36. 7.6.5 Mylan Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Voriconazole Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 GSK
  44. 7.8.1 GSK Company Information
  45. 7.8.2 GSK Business Overview
  46. 7.8.3 GSK Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GSK Voriconazole Product Portfolio
  48. 7.8.5 GSK Recent Developments
  49. 7.9 Taj Pharmaceuticals
  50. 7.9.1 Taj Pharmaceuticals Company Information
  51. 7.9.2 Taj Pharmaceuticals Business Overview
  52. 7.9.3 Taj Pharmaceuticals Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Taj Pharmaceuticals Voriconazole Product Portfolio
  54. 7.9.5 Taj Pharmaceuticals Recent Developments
  55. 7.10 Squibb
  56. 7.10.1 Squibb Company Information
  57. 7.10.2 Squibb Business Overview
  58. 7.10.3 Squibb Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Squibb Voriconazole Product Portfolio
  60. 7.10.5 Squibb Recent Developments
  61. 7.11 Sichuan Beauty Sport Huakang Pharmaceutical
  62. 7.11.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
  63. 7.11.2 Sichuan Beauty Sport Huakang Pharmaceutical Business Overview
  64. 7.11.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio
  66. 7.11.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments
  67. 7.12 Macherey-Nagel GmbH
  68. 7.12.1 Macherey-Nagel GmbH Company Information
  69. 7.12.2 Macherey-Nagel GmbH Business Overview
  70. 7.12.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Macherey-Nagel GmbH Voriconazole Product Portfolio
  72. 7.12.5 Macherey-Nagel GmbH Recent Developments
  73. 7.13 Jincheng HEALTH Pharmaceutical
  74. 7.13.1 Jincheng HEALTH Pharmaceutical Company Information
  75. 7.13.2 Jincheng HEALTH Pharmaceutical Business Overview
  76. 7.13.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio
  78. 7.13.5 Jincheng HEALTH Pharmaceutical Recent Developments
  79. 7.14 GeneTech Pharm
  80. 7.14.1 GeneTech Pharm Company Information
  81. 7.14.2 GeneTech Pharm Business Overview
  82. 7.14.3 GeneTech Pharm Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 GeneTech Pharm Voriconazole Product Portfolio
  84. 7.14.5 GeneTech Pharm Recent Developments
  85. 7.15 Ebang Pharmaceutical
  86. 7.15.1 Ebang Pharmaceutical Company Information
  87. 7.15.2 Ebang Pharmaceutical Business Overview
  88. 7.15.3 Ebang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ebang Pharmaceutical Voriconazole Product Portfolio
  90. 7.15.5 Ebang Pharmaceutical Recent Developments
  91. 7.16 Daiichi Sankyo
  92. 7.16.1 Daiichi Sankyo Company Information
  93. 7.16.2 Daiichi Sankyo Business Overview
  94. 7.16.3 Daiichi Sankyo Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Daiichi Sankyo Voriconazole Product Portfolio
  96. 7.16.5 Daiichi Sankyo Recent Developments
  97. 7.17 Cilag AG
  98. 7.17.1 Cilag AG Company Information
  99. 7.17.2 Cilag AG Business Overview
  100. 7.17.3 Cilag AG Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Cilag AG Voriconazole Product Portfolio
  102. 7.17.5 Cilag AG Recent Developments
  103. 7.18 Aditya Pharma
  104. 7.18.1 Aditya Pharma Company Information
  105. 7.18.2 Aditya Pharma Business Overview
  106. 7.18.3 Aditya Pharma Voriconazole Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Aditya Pharma Voriconazole Product Portfolio
  108. 7.18.5 Aditya Pharma Recent Developments
8 North America
  1. 8.1 North America Voriconazole Market Size by Type
  2. 8.1.1 North America Voriconazole Revenue by Type (2021-2032)
  3. 8.1.2 North America Voriconazole Sales by Type (2021-2032)
  4. 8.1.3 North America Voriconazole Price by Type (2021-2032)
  5. 8.2 North America Voriconazole Market Size by Application
  6. 8.2.1 North America Voriconazole Revenue by Application (2021-2032)
  7. 8.2.2 North America Voriconazole Sales by Application (2021-2032)
  8. 8.2.3 North America Voriconazole Price by Application (2021-2032)
  9. 8.3 North America Voriconazole Market Size by Country
  10. 8.3.1 North America Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Voriconazole Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Voriconazole Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Voriconazole Market Size by Type
  2. 9.1.1 Europe Voriconazole Revenue by Type (2021-2032)
  3. 9.1.2 Europe Voriconazole Sales by Type (2021-2032)
  4. 9.1.3 Europe Voriconazole Price by Type (2021-2032)
  5. 9.2 Europe Voriconazole Market Size by Application
  6. 9.2.1 Europe Voriconazole Revenue by Application (2021-2032)
  7. 9.2.2 Europe Voriconazole Sales by Application (2021-2032)
  8. 9.2.3 Europe Voriconazole Price by Application (2021-2032)
  9. 9.3 Europe Voriconazole Market Size by Country
  10. 9.3.1 Europe Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Voriconazole Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Voriconazole Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Voriconazole Market Size by Type
  2. 10.1.1 China Voriconazole Revenue by Type (2021-2032)
  3. 10.1.2 China Voriconazole Sales by Type (2021-2032)
  4. 10.1.3 China Voriconazole Price by Type (2021-2032)
  5. 10.2 China Voriconazole Market Size by Application
  6. 10.2.1 China Voriconazole Revenue by Application (2021-2032)
  7. 10.2.2 China Voriconazole Sales by Application (2021-2032)
  8. 10.2.3 China Voriconazole Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Voriconazole Market Size by Type
  2. 11.1.1 Asia Voriconazole Revenue by Type (2021-2032)
  3. 11.1.2 Asia Voriconazole Sales by Type (2021-2032)
  4. 11.1.3 Asia Voriconazole Price by Type (2021-2032)
  5. 11.2 Asia Voriconazole Market Size by Application
  6. 11.2.1 Asia Voriconazole Revenue by Application (2021-2032)
  7. 11.2.2 Asia Voriconazole Sales by Application (2021-2032)
  8. 11.2.3 Asia Voriconazole Price by Application (2021-2032)
  9. 11.3 Asia Voriconazole Market Size by Country
  10. 11.3.1 Asia Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Voriconazole Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Voriconazole Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Voriconazole Market Size by Type
  2. 12.1.1 SAMEA Voriconazole Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Voriconazole Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Voriconazole Price by Type (2021-2032)
  5. 12.2 SAMEA Voriconazole Market Size by Application
  6. 12.2.1 SAMEA Voriconazole Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Voriconazole Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Voriconazole Price by Application (2021-2032)
  9. 12.3 SAMEA Voriconazole Market Size by Country
  10. 12.3.1 SAMEA Voriconazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Voriconazole Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Voriconazole Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Voriconazole Value Chain Analysis
  2. 13.1.1 Voriconazole Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Voriconazole Production Mode & Process
  6. 13.2 Voriconazole Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Voriconazole Distributors
  9. 13.2.3 Voriconazole Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst